Slide 1 Is Marijuana Medicine?

Size: px
Start display at page:

Download "Slide 1 Is Marijuana Medicine?"

Transcription

1 Slide 1 Is Marijuana Medicine? Perspectives, Potentials, & Problems Allan Barger, MSW PRI Research Analyst Slide 2 Presentation Goals Define terms Identify and explain the human endocannabinoid system and its importance Distinguish between medical marijuana types and use versus recreational use Identify THC and other plant-based cannabinoids with proposed medical uses Present research on potential medical uses of those cannabinoids Summarize research on problems of marijuana use and cautions on medical use Leave the training with therapeutically appropriate responses to frequent questions Copyright 2018, Prevention Research Institute. Slide 3 Medical Marijuana Why Hold This Session? Why Not Medical Opium? The prevention and treatment fields have legitimate public health concerns. Copyright 2018, Prevention Research Institute. 1

2 Slide 4 Medical Use? Colorado Medical Marijuana Users Slide 5 Medical Use? Mingling of medical and recreational use terminology creates resistance to cannabis use disorder treatment in people with no medical reason to use marijuana. Slide 6 Medical Use? A professional colleague notes: We see people in our clinic with severe marijuana use disorders who state the only thing they want put into their care plan is to move to Colorado. --Julie Schumacher-Coffey, PhD 2

3 Slide 7 What Is Marijuana? -THC, CBD, THCA, & More The media talk imprecisely about very different compounds found in cannabis, often simply using the term marijuana. This leads the public to assume smoking a joint will produce medical benefits, with little to no recognition of risks or other important issues such as type of substance, dosing, frequency, route of administration, and lack of clinical trials. Slide 8 Medical Marijuana Defining Our Terms Is marijuana a medicine? Slide 9 A medicine is defined as a compound used for treatment or prevention of disease This definition suggests marijuana is a medicine, best known for treating nausea. Marijuana is a crude medicine, similar to drinking willow-bark tea the crude source for aspirin for a headache. Medical Marijuana 3

4 Slide 10 Medical Cannabinoids To get beyond a crude medicine, we need to look into marijuana more closely, at the compounds that supply medical benefits. We need to explore the cannabinoids, a class of substances that bind to the human cannabinoid receptors. Slide 11 Marijuana Defining Our Terms What is a cannabinoid and why should you care? Slide 12 Cannabinoids 3 Types of Cannabinoids Endocannabinoids all mammals other species Phytocannabinoids cannabis sativa other plants, e.g. echinacea, black pepper, black truffle, chocolate Synthetic cannabinoids JWH-018 nabilone (Cesamet ) 4

5 Slide 13 Endocannabinoid system (or the endogenous cannabinoid system) This system is made up of: Neuro chemicals Anandamide (AEA) 2-archidonoylglycerol (2-AG) Noladin ether Palmitoylethanolamide (PEA) Virodhamine (agonist/antagonist) Endocannabinoid System Copyright 2018, Prevention Research Institute. Slide 14 Neurotransmitters Most brain chemicals are neurotransmitters Slide 15 Endocannabinoid System Endogenous cannabinoids are not neurotransmitters! They help regulate and adjust the flow of neurotransmitters, so that those other neurochemicals do their work most efficiently. This means: 5

6 Slide 16 Endocannabinoid System Endogenous cannabinoids are NeuroMODULATORS! Slide 17 Endocannabinoid system (or the endogenous cannabinoid system) This system is made up of: Neuromodulators Anandamide (AEA) 2-archidonoylglycerol (2-AG) Noladin ether Palmitoylethanolamide (PEA) Virodhamine (agonist/antagonist) Endocannabinoid System Slide 18 Endocannabinoid System Endocannabinoid system (or the endogenous cannabinoid system) This system is also made up of: Receptors in body & brain CB1 (cannabinoid receptor 1) CB2 (cannabinoid receptor 2) PPAR- (peroxisome proliferator-activated receptor- ) 6

7 Slide 19 Endocannabinoid system (or the endogenous cannabinoid system) Endocannabinoid System This system is made up of: Neuromodulators Anandamide (AEA) -- CB1 & CB2 2-archidonoylglycerol (2-AG) CB2 & CB1 Noladin ether CB1 & CB2 Palmitoylethanolamide (PEA) -- PPAR- (nucleus receptor) Virodhamine (agonist/antagonist) -- CB1 & GPR55 Modulate multiple functions including: Genetic protein production Body temperature Appetite Pain reception Inflammation Aggression Neurological development Copyright 2018, Prevention Research Nausea & vomiting Institute. many more Slide 20 Endocannabinoid System Slide 21 Endocannabinoid system (or the endogenous cannabinoid system) Endocannabinoid System This system is completed by: Metabolizing Chemicals FAAH (fatty acid amide hydrolase) metabolizes anandamide & PEA MAGL or MGLL (monoacyl glycerol lipase) metabolizes 2-AG Copyright 2018, Prevention Research Institute. 7

8 Slide 22 Endocannabinoid System Activity in the endocannabinoid system has potential for both therapies and problems. Slide 23 Marijuana Defining Our Terms What does marijuana mean? Forms and Routes of Administration Slide 24 Marijuana Sativa vs Indica? 8

9 Slide 25 Marijuana, Weed, Bud Recreational Use = THC weed = dried bud of the marijuana plant sensemilla = growing process - the female plant is not fertilized - no seeds smoked or heated to inhale THC vapor THC content 4 12% Marijuana Slide 26 Dabs, Wax, Shatter Recreational Use Butane Hash Oil (BHO) refined into Dab wax or shatter resin placed on superheated metal - resulting vapor inhaled Can be used in e-cigarettes THC concentration is 23-76% 80% contaminated with residual pesticides or solvents Marijuana Slide 27 Metabolism A little pharmacology Marijuana s most common cannabinoid is 9 -tetrahydrocannabinol ( 9 -THC) and is psychoactive It metabolizes into two substances Hydroxy-Δ9-tetrahydrocannabinol (hydroxy-thc) is psychoactive nor-9-carboxy-Δ9-tetrahydrocannabinol (carboxy-thc ) persists in the body, blood and urine but is non-psychoactive. Copyright 2018, Prevention Research Institute. 9

10 Slide 28 Marijuana Edible Marijuana Copyright 2018, Prevention Research Institute. Slide 29 Marijuana Edible Marijuana The dosing problem An estimated 16% to 26% of patients using medical cannabis consume edible products, JAMA says, and even though oral consumption lacks the harmful by-products of smoking, difficult dose titration can result in overdosing or underdosing, highlighting the importance of accurate product labeling. Slide 30 Metabolism A little pharmacology THC from edible marijuana is first metabolized in the liver: Slower onset of effect (30 min 2 hrs) and the high may last longer Higher levels of hydroxy-thc Higher risk of greater-than-intended impairment, less control of dosing 10

11 Slide 31 Medical Marijuana Defining Our Terms Marijuana Permits are Not Prescriptions The AMA has requested professionals avoid the term prescription. Prescriptions are medical documents defining a treatment protocol Marijuana cards are legal documents permitting use. Slide 32 Medical Marijuana? There are over 100 cannabinoid compounds in Cannabis sativa 9 -Tetrahydrocannabinol ( 9- THC) Cannabidiol (CBD) 8 -THC Cannabinol (CBN) Cannabichromene Cannibigerol. Etc. Few have any significant clinical investigation, although some are being investigated. Slide 33 What Is Marijuana? Primary Compounds -THC & CBD For our purposes mostly focus 9 -THC = THC cannabidiol = CBD 11

12 Slide 34 Medical Use Differing Forms of Marijuana THC smoked in plant matter Cannabidiol (CBD) in oil o CBD content about 4 7% with THC as low as 0.3% Butane Hash Oil (Dabs/Shatter) Medical Marijuana Rick Simpson Oil (RSO) whole plant extract, THC & CBD + Copyright 2018, Prevention Research Institute. other cannabinoids Slide 35 What Is Marijuana? Primary Compound -THC THC potential medical benefits: Anti-nausea Appetite stimulant Analgesic THC potential negative effects: Tolerance and Dependence Acute & Lingering Cognitive impairment Psychotogenic Copyright 2018, Prevention Research Institute. Slide 36 What Is Marijuana? CBD (cannabidiol) CBD - antioxidant opposing many THC effects including the high anti-inflammatory, anti-seizure, anti-psychotic, and anti-tumor (shrinks cancer tumors) Helps reduce muscle spasms and tremors in diseases multiple sclerosis and possibly Parkinson s Disease & Huntington s Disease 12

13 Slide 37 Canabidiol (CBD) What Is Marijuana? Cannabidiol exhibits an impressive plethora of actions, including anticonvulsive, sedative, hypnotic, antipsychotic, antiinflammatory and neuroprotective properties, many of which may be of therapeutic relevance as well as serving as leads for pharmaceutical development. Scuderi, C., Filippis, D. D., Iuvone, T., Blasio, A., Steardo, A., & Esposito, G. (2009). Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders. Phytotherapy Research, 23(5), Slide 38 Medical Marijuana Cannabidiol as Medicine Slide 39 Medical Marijuana Marijuana Formulations -THC (a.k.a. Water Clear) 13

14 Slide 40 Medical Marijuana Marijuana Formulations Sativex (nabiximols) 2.7 mg - THC & 2.5 mg - CBD Used in treatment of multiple sclerosis Spasm Pain Copyright 2018, Prevention Research Institute. All Rights Reserved Slide 41 Medical Marijuana Tetrahydocannabinolic Acid (THCA) THCA precursor compound to 9 -THC Non-psychoactive Requires decarboxylation via heat to become THC Has medical uses Copyright 2018, Prevention Research Institute. All Rights Reserved Slide 42 Medical Marijuana Marijuana Formulations Oral Cannabis Extracts Vary in Content CBD & THC-A may be available in non-mmj states May help or harm Contaminants are common Solvents Pesticides Caveat Emptor 14

15 Slide 43 Marinol (dronabinol) Medical Marijuana Semi-synthetic Cannabinoids Slide 44 Medical Marijuana Synthetic Cannabinoids Cesamet (nabilone) Slide 45 Synthetic Cannabinoids Synthetic cannabinoids developed for medical purposes with mixed success nabilone (Cesamet) levonantradol rimonabant (Acomplia) 15

16 Slide 46 Cancer Does marijuana cure cancer? Slide 47 Cancer So, I did. Slide 48 Cancer Dr. Abrams opinion reflects a consensus within the credible oncologist and cancer scientific community: there is no doubt that cannabis is effective at treating cancer-related symptoms and treatment-related side effects, but the jury is still out on whether cannabis can actually cure cancer. 16

17 Slide 49 Cancer More recently, scientists reported that THC and other cannabinoids such as CBD slow growth and/or cause death in certain types of cancer cells growing in lab dishes. Some animal studies also suggest certain cannabinoids may slow growth and reduce spread of some forms of cancer. There have been some early clinical trials of cannabinoids in treating cancer in humans and more studies are planned. While the studies so far have shown that cannabinoids can be safe in treating cancer, they do not show that they help control or cure the disease. Relying on marijuana alone as treatment while avoiding or delaying conventional medical care for cancer may have serious health consequences. Slide 50 GreenState Cancer Cannabis is well established as a treatment for the side effects of cancer and chemotherapy, like nausea, vomiting, pain, anxiety, insomnia, and lack of appetite. But in a comprehensive review of the cannabis literature, researchers from the National Academies of Sciences, Engineering and Medicine found there to be insufficient evidence to say that cannabis can treat cancer directly. Without large scale, placebo controlled clinical trials, doctors and researchers don t have the solid evidence they d need to recommend cannabis for cancer treatment. Slide 51 Meta-analysis Meta-analysis of dronabinol, nabilone, levonantradol The three cannabinoids resulted in greater adverse drug effects compared to the controls. There was a significant increase in the number of patients who withdrew from the studies due to intolerable adverse drug effects in 19 of the 30 trials. The increased adverse drug effects were described as being beneficial or harmful. The beneficial adverse effects included sensation of a high, euphoria, drowsiness, sedation, and somnolence. The harmful adverse effects included dysphoria, depression, hallucination, and paranoia. Cannabinoids also increased the risk of arterial hypotension (>20% decrease in blood pressure from baseline) in patients. This meta-analysis showed that one in eleven patients would stop chemotherapy treatment if taking a cannabinoid for antiemesis compared to no patients discontinuing treatment if prescribed another antiemetic. 17

18 Slide 52 Cancer Does marijuana cure cancer? Slide 53 Crohn s Disease/IBS Cannabinoids & Bowel Disorders Slide 54 Epilepsy Does Marijuana Cure Epilepsy? 18

19 Slide 55 Glaucoma Do es M ar ij u an a t r eat Glau co m a Slide 56 HIV/AIDS Does Marijuana treat HI V/ AI DS Slide 57 Neurologic Disorders American Academy of Neurology use of cannabinoids in neurologic disorders Koppel, B. S., Brust, J. C., Fife, T., Bronstein, J., Youssof, S., Gronseth, G., & Gloss, D. (2014). Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology, 82(17), thc 19

20 Slide 58 Neurologic Disorders Cannabinoids for Medical Use A system atic review Slide 59 PTSD Does Marijuana treat PTSD Slide 60 Opioid Use Disorder Marijuana & Opioid Use Disorder 20

21 Slide 61 Multiple Sclerosis Marijuana & Multiple Sclerosis Slide 62 Neurologic Disorders Cannabinoids for Medical Use A system atic review Slide 63 Cannabis Problems What are the risks? Most related to THC 1. Adolescent Use linked to multiple problems 2. Acute Impairment 3. Cognitive deficits 4. Cannabis Use Disorder/Addiction 5. Health Problems - rare but devastating 21

22 Slide 64 Cannabis Problems Dependence & Addiction 2014 NESARC found nearly 6 million U.S. citizens aged 18+ met criteria for a DSM-5 cannabis use disorder. Cannabis use disorder exceeds prevalence of all other SUD other than alcohol. Slide 65 Cannabis Problems Dependence & Addiction NESARC data - 3 year relapse rate for cannabis use disorder (CUD) was 6.3%, but: This is a higher rate than the 5.1% for alcohol dependence over the same time frame; The average length of time from meeting CUD diagnostic criteria to recovery is 6 years; One third continue using for over a decade after meeting dependence criteria Slide 66 Cannabis Problems Rare but Devastating 1. Psychosis Disorders Subclinical but serious schizotypal symptoms Schizotypal Personality Disorder Schizophrenia 2. Testicular/Prostate Cancer Nonseminomous germ cell tumor in men (2x greater risk in marijuana users vs nonusers) Prostate cancer (4.7 relative risk in non-tobacco smokers using marijuana) 22

23 Slide 67 Cannabis Problems Rare (?) but Devastating 3. Cardiovascular Events In April 2014 the American Heart Association published a Physician Alert cautioning doctors to begin enquiring about cannabis use. 4. Cannabis Hyperemesis Syndrome Uncontrolled vomiting after several years of marijuana use, coupled with hot baths to ease the symptoms. We don t know how widespread this is. The only known treatment is abstinence from marijuana. Slide 68 Potentials JAMA on Medical Marijuana Conclusions and Relevance : There was moderate-quality evidence to support the use of cannabinoids for the treatment of chronic pain and spasticity. There was low-quality evidence cannabinoids were associated with improvements in nausea and vomiting due to chemotherapy, weight gain in HIV infection, sleep disorders, and Tourette syndrome. Cannabinoids were associated with an increased risk of short-term AEs*. D'souza, D. C., & Ranganathan, M. (2015). Medical marijuana: Is the cart before the horse?. JAMA, 313(24), [*AEs = Adverse Events a.k.a unwanted outcomes] Slide 69 Potentials JAMA on Medical Marijuana Moderate Quality Evidence Chronic pain such as in cancer or HIV neuropathy Spasticity as seen in multiple sclerosis Low Quality Evidence - Studies are often observational, not controlled clinical trials PTSD Crohn s Disease 23

24 Slide 70 Potentials There is a lot we do not yet know: Public referendums, legislative authorization, (and Federal regulations) defeat our medical system set up to find out: What works? What are the effects? How does it interact with other drugs? What is safe (acceptable risk)? What are the risks for different groups? Who should and should not use it? Slide 71 Summary Marijuana is a crude medicine, but there appear to be some legitimate medical uses. Our current legislative/proposition system shortcircuits medical research on effective use for needy populations. The current legislative/proposition system defeats regulatory controls on production and distribution Clients and the public do not distinguish well between medicinal and recreational use This increases risk for pubic health problems and complicates our work in mental health. Slide 72 Contact Us Allan Barger, MSW PRI Research Analyst 24

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only CDHA 2016 Fall Symposium Speaker Handout Files For registered attendees only Providing Care in a Marijuana Legal World Heather Rogers, BSDH heatherrdh@heatherrdh.com Objectives We will discuss some of

More information

MEDICAL MARIJUANA: WHAT S THE EVIDENCE?

MEDICAL MARIJUANA: WHAT S THE EVIDENCE? MEDICAL MARIJUANA: WHAT S THE EVIDENCE? L A U R A A. M A R K L E Y, M D B O A R D - C E R T I F I E D I N P E D I A T R I C S / G E N E R A L P S Y C H I A T R Y / C H I L D & A D O L E S C E N T P S Y

More information

A look at Marijuana in 2014

A look at Marijuana in 2014 A look at Marijuana in 2014 Paul Snyder MA., LADC Overview and Objectives Discuss the mental and physical effects of marijuana use Describe the criteria for Cannabis use disorder according to the DSM 5

More information

Research on Cannabis and PD: Is there any evidence?

Research on Cannabis and PD: Is there any evidence? Research on Cannabis and PD: Is there any evidence? Benzi M. Kluger, MD, MS Associate Professor of Neurology and Psychiatry Director Movement Disorders Center University of Colorado Denver DISCLOSURES

More information

The Return of Medicinal Cannabis

The Return of Medicinal Cannabis The Return of Medicinal Cannabis George Kolodner, M.D. DLFAPA FASAM Chief Clinical Officer Clinical Professor of Psychiatry Georgetown University School of Medicine University of Maryland School of Medicine

More information

Cannabis. Member of the Cannabaceae family of flowering plants (along with hops) Cannabis sativa (v. sativa, indica, afghanica, ruderalis)

Cannabis. Member of the Cannabaceae family of flowering plants (along with hops) Cannabis sativa (v. sativa, indica, afghanica, ruderalis) Member of the Cannabaceae family of flowering plants (along with hops) sativa (v. sativa, indica, afghanica, ruderalis) Only females flowers contain high concentrations of psychoactive oils (cannabinoids)

More information

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic Medical Cannabis Danial Schecter, MD, CCFP Executive Director Cannabinoid Medical Clinic Vocational Rehabilitation Association November 7th, 2014 Conflict of Interest This program has not received financial

More information

Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.

Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure. Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center Controversies in Pain Management Conference Johnson City, TN November 13, 2015 Disclosure

More information

Medical Cannabis MATT WEBSTER DO, MS

Medical Cannabis MATT WEBSTER DO, MS Medical Cannabis MATT WEBSTER DO, MS Cannabis Sativa One of the oldest used drugs and medicinal remedies Most commonly abused illicit drug in the US There has been increasing access for medicinal MJ use

More information

Medical vs Recreational Use of Cannabis. 11 th December 2017

Medical vs Recreational Use of Cannabis. 11 th December 2017 1 Medical vs Recreational Use of Cannabis 11 th December 2017 2 Defining Cannabis and Chemical Constituents Cannabis is a plant species. Two main Cannabis sub-species are Cannabis Sativa and Cannabis Indica.

More information

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility. Medical Marijuana Questions from Part 1: 1. is a plant species, variety known as hemp. a. Cannabis sativa Linnaeus b. Cannabis sativa c. Cannabis indica d. Cannabis Lemark 2. The major psychoactive compound

More information

Pennsylvania House of Representatives. Joint Health and Judiciary Committee Hearing. Medical Cannabis - Health Care Forum

Pennsylvania House of Representatives. Joint Health and Judiciary Committee Hearing. Medical Cannabis - Health Care Forum Pennsylvania House of Representatives Joint Health and Judiciary Committee Hearing Medical Cannabis - Health Care Forum Tuesday, March 24, 2015 Philadelphia, Pennsylvania Testimony offered by: David J.

More information

Acknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making

Acknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making Cannabis Evidence Series What it is What it s not Acknowledgements: The evidence presented is from the Cannabis evidence series authored by the HTA unit at the University of Calgary and from Rapid response

More information

Use of Cannabinoids in Medical Practice

Use of Cannabinoids in Medical Practice Use of Cannabinoids in Medical Practice Annual Scientific Assembly Family Medicine Review 2016 Murray Opdahl BSPE, MD, CCFP Objectives Briefly present: An overview of available cannabinoids Concerns voiced

More information

CANNABIS FOR THE RHEUMATOLOGIST

CANNABIS FOR THE RHEUMATOLOGIST CANNABIS FOR THE RHEUMATOLOGIST Dr Jagtar Singh Nijjar NIHR Clinical Lecturer in Rheumatology Disclosures None 1 Overview The history of cannabis use Anecdotal use of cannabis in chronic pain The biology

More information

CBD and Your Health.

CBD and Your Health. CBD and Your Health. Cannabidiol (CBD) is a molecule found in plant species such as agricultural (or industrial) hemp, and Echinacea. CBD is one of at least 489 distinct compounds within hemp: it is clear

More information

The Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy

The Effects known & unknown of Marijuana in Older Adults. Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy The Effects known & unknown of Marijuana in Older Adults Danielle Fixen, PharmD, BCGP, BCPS University of Colorado School of Pharmacy Learning Objectives 1. Review various dosing strategies for medical

More information

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system Medicinal cannabis What is medicinal cannabis? Broadly speaking, medicinal cannabis is cannabis prescribed to relieve the symptoms of a medical condition, such as epilepsy. It is important to make the

More information

ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP

ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP Page 1 1. In what year did the possession and transfer of cannabis for recreational use become illegal in the United States? A. 1937 B. 1941 C. 1933 2.

More information

Medical Marijuana: The Move to Schedule II

Medical Marijuana: The Move to Schedule II Medical Marijuana: The Move to Schedule II David Deitz, MD, PhD David Deitz & Associates Today s discussion Does medical marijuana actually treat anything? What are the workplace issues? What are the interactions

More information

Marijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US

Marijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US Marijuana and Adolescents: Truth and Consequences Clinical Advances in Pediatrics Symposium Children s Mercy Park September 28, 2017 Disclosure Statement I have no actual or potential conflict of interest

More information

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD Speaker Disclosures We have/had no financial relationships with any commercial interests

More information

Legalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine

Legalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine Legalized Marijuana: Uses, Misuses & Abuses Kennon Heard University of Colorado SOM Dept Of Emergency Medicine Disclosures Research grants McNeil Consumer Healthcare (Acetaminophen) Rare Disease Therapeutics

More information

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada My Agenda Discuss the best available evidence Put the evidence into

More information

4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION

4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION Susan R Davidson, MD Maternal Fetal Medicine Department of Ob/Gyn St. Mary s Hospital Madison, WI SSM Health I HAVE NO FINANCIAL DISCLOSURES TO REPORT

More information

THE COMPLETE CBD GUIDE

THE COMPLETE CBD GUIDE THE COMPLETE CBD GUIDE WHAT IS CBD (CANNABIDIOL)? 2 WHERE DOES CBD COME FROM? 3 HOW DOES CBD WORK IN THE BODY? 4 HOW MUCH CBD DO I TAKE? 5-6 CBD OIL VS. HEMP OIL 7 CBD NOT THC 8 THE BENEFITS OF CBD 9 PETS

More information

Cannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD

Cannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD Cannabidiol as a potential treatment for anxiety disorders Esther Blessing, MD PhD Overview History and of cannabidiol (CBD) and cannabis Safety and tolerability of CBD CBD pharmacology Clinical need for

More information

History Of Medical Cannabis

History Of Medical Cannabis History Of Medical Cannabis Historical and archaeological evidence of widespread use in ancient times as medicine, food, textiles & for sacraments, rituals Possibly first domesticated crop Introduction

More information

Marijuana and the Chronic Non-Cancer Pain Patient

Marijuana and the Chronic Non-Cancer Pain Patient Marijuana and the Chronic Non-Cancer Pain Patient Kevin P. Hill, M.D., M.H.S. Pain 101: Provider Workshop 9/23/16 McLean Hospital Division of Alcohol and Drug Abuse khill@mclean.harvard.edu DrKevinHill.com,

More information

Medical Marijuana Consent Form

Medical Marijuana Consent Form Medical Marijuana Consent Form A qualified physician may not delegate the responsibility of obtaining written informed consent to another person. The qualified patient or the patient s parent or legal

More information

9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures.

9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section Disclosures Site principal investigator of studies of cannabidiol(epidiolex) in the treatment of

More information

DESCRIPTION DURATION

DESCRIPTION DURATION NAME DESCRIPTION DURATION 5 Basic Cannabis Questions Answered - Leafly 412 5 Differences Between Eating and Smoking Cannabis - Leafly 351 5 Things You Didn't Know About MMJ - Civilized 0 A Short History

More information

(THC) Delta9-tetrahydrocannabinol:

(THC) Delta9-tetrahydrocannabinol: (THC) Delta9-tetrahydrocannabinol: Most prominent compound found in the cannabis plant found in the 1960 s. THC binds to the CB1 and CB2 receptors causing a change in the function of the cell it is binding.

More information

MARIJUANA in MEDICAL CARE READY or RISKY. HINDI MERMELSTEIN, MD FAPM Beth Israel Medical Center, NYC Dec

MARIJUANA in MEDICAL CARE READY or RISKY. HINDI MERMELSTEIN, MD FAPM Beth Israel Medical Center, NYC Dec MARIJUANA in MEDICAL CARE READY or RISKY HINDI MERMELSTEIN, MD FAPM drhmermelstein @optimum.net Beth Israel Medical Center, NYC Dec 11 2015 HISTORY MARIJUANA (CANNABIS SAVITA) HAS LONG BEEN PART OF RELIGIOUS

More information

Medical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015

Medical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015 Medical Marijuana Kent W. Peterson, MD, FACOEM Occupational Health Strategies, Inc. Charlottesville, VA Speaker Disclosure Requirements 1. Do not dispense, prescribe, refer or recommend MMJ 2. Have no

More information

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access Medical Marijuana Deb Evans, RN, MScN, CON(C), CHPCN(C) Clinical Nurse Specialist Pain and Symptom Management Team Juravinski Cancer Centre May 29, 2014 Objectives 1. Review controversy 2. Pathophysiology

More information

Medical Marijuana A Primer for Pharmacists

Medical Marijuana A Primer for Pharmacists Medical Marijuana A Primer for Pharmacists Emory S. Martin, PharmD FASHP Texas Society of Health System Pharmacists Learning Objectives Recognize key components of the endocannabinoid system Identify possible

More information

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Stephanie Abel, PharmD, BCPS Palliative Medicine Clinical Pharmacy Specialist James Cancer Hospital The Ohio State

More information

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids

Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Medical Marijuana A Brief Overview of the Program in Ohio and Pharmacology of Cannabinoids Stephanie Abel, PharmD, BCPS Palliative Medicine Clinical Pharmacy Specialist James Cancer Hospital The Ohio State

More information

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level. Introduction This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level. Definition: The term "extracts and tinctures" refers to substances that

More information

I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people

I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people Introduction to the Cannabinoid System And Medical Use Dr Alia Norman Radiation Oncologist Cannabinoid

More information

Is the most common illicit drug used in the United States. After a period of decline in the last decade, its use has been increasing among young

Is the most common illicit drug used in the United States. After a period of decline in the last decade, its use has been increasing among young The Facts Cannabis, commonly known as marijuana and by numerous other names, is a preparation of the cannabis plant intended for use as a psychoactive drug and now as medicine. Marijuana also refers to

More information

Learning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages

Learning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD CECILIA HILLARD, PHD DEPARTMENT OF PHARMACOLOGY NEUROSCIENCE RESEARCH CENTER Disclosures Member of the Scientific Advisory Board

More information

WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2

WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2 WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis Expert Peer Review 2 1. Comments based on the review report a. Evidence on dependence and abuse potential Extracts

More information

Federal Law: Marijuana

Federal Law: Marijuana Federal Law: Marijuana Marijuana is a Schedule I drug under Federal Controlled Substances Act Makes possession, usage, purchase, sale, and/or cultivation of marijuana illegal at the federal level May not

More information

Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer

Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer Medicinal cannabinoids where does it fit in Palliative Care? Janet Hardy Phillip Good Georgie Cupples Matthew Spitzer Medicinal cannabis Substantial public interest Legalised by the Qld Government Guidance

More information

CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS

CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS 1. GENERAL INFORMATION Cannabis 101 What is cannabis? Cannabis is a product derived from the Cannabis sativa plant. Cannabis contains hundreds

More information

Medical Marihuana for Patients in the Lymphoma Setting. Speakers: Ruth Turner, RN, Con Rob Laister, PhD

Medical Marihuana for Patients in the Lymphoma Setting. Speakers: Ruth Turner, RN, Con Rob Laister, PhD Medical Marihuana for Patients in the Lymphoma Setting Speakers: Ruth Turner, RN, Con Rob Laister, PhD Medical Marihuana for Patients in the Lymhoma Setting Disclosure: No endorsement or promotion of marihuana

More information

A summary of reviews of evidence on the efficacy and safety of medical use of cannabis and cannabinoids

A summary of reviews of evidence on the efficacy and safety of medical use of cannabis and cannabinoids A summary of reviews of evidence on the efficacy and safety of medical use of cannabis and cannabinoids Background paper commissioned by the EMCDDA for the report Medical use of cannabis and cannabinoids:

More information

Medical Marijuana. Navigating Medical Marijuana in Workers Compensation

Medical Marijuana. Navigating Medical Marijuana in Workers Compensation Medical Marijuana Navigating Medical Marijuana in Workers Compensation Agenda Federal and State Laws Public Health Adverse Effects & Concerns Clinical Use Implications for Employers Implications for Workers

More information

420 ADVISORY MANAGEMENT

420 ADVISORY MANAGEMENT THE CANNABIS ACT: WHAT DOES IT MEAN FOR CANADIANS? 420 CLINIC, LTD. OBJECTIVES At the end of the session, you will be able to: 1) Understand the ramifications of recreational cannabis legalization 2) Understand

More information

MEDICAL CANNABIS IN MINNESOTA

MEDICAL CANNABIS IN MINNESOTA MEDICAL CANNABIS IN MINNESOTA MINNESOTA ACADEMY OF PHYSICIAN ASSISTANTS MARCH 18, 2016 TOM ARNESON, MD, MPH MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program

More information

Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University

Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University sgkinsey@mail.wvu.edu Any opinions expressed are my own and do not reflect any official position of WVU beanpot.co

More information

USING ALTERNATIVE MEDICATION: MEDICAL CANNABIS (MARIJUANA)--BENEFITS AND HARMFUL EFFECTS JENNIFER KAPUR, PHARM.D. MARCH 1, 2016

USING ALTERNATIVE MEDICATION: MEDICAL CANNABIS (MARIJUANA)--BENEFITS AND HARMFUL EFFECTS JENNIFER KAPUR, PHARM.D. MARCH 1, 2016 USING ALTERNATIVE MEDICATION: MEDICAL CANNABIS (MARIJUANA)--BENEFITS AND HARMFUL EFFECTS JENNIFER KAPUR, PHARM.D. MARCH 1, 2016 OBJECTIVES Compare and contrast federal law and state laws regarding marijuana

More information

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will

More information

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana Connie J. Cerilli, APRN, FNP-C Outcome Participants will be able to list 3 approved medical conditions Participants will

More information

The Scientific Side of Medical Marijuana

The Scientific Side of Medical Marijuana The Scientific Side of Medical Marijuana Ken Mackie, MD Indiana University Bloomington, IN December 3, 2009 kmackie@indiana.edu Financial disclosures NIH (NIDA) - research grants Alzheimer s Association

More information

Cannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017

Cannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017 Cannabis and What we Know Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017 We All Have a Role to Play! Objectives What is Cannabis? What do we know about the health effects? Legalization:

More information

Cannabis Use: Scope of the Issue

Cannabis Use: Scope of the Issue Three Areas of Focus How Changing Cannabis Policy Will Affect Your Practice Kevin P. Hill, MD, MHS Director, McLean Hospital Division of Alcohol and Drug Abuse Belmont, MA Assistant Professor of Psychiatry,

More information

Medical Cannabis use in the Older Patient

Medical Cannabis use in the Older Patient Medical Cannabis use in the Older Patient Dr. Amanjot Sidhu Division of Geriatric Medicine McMaster University Audience Poll What is the fastest-growing demographic of cannabis users? a) Ages 14-23 b)

More information

POLICY NUMBER: POL 153

POLICY NUMBER: POL 153 Chapter: CLAIMS Subject: MEDICAL CANNABIS Effective Date: October 25, 2018 Last Update: October 25, 2018 PURPOSE STATEMENT The purpose of this policy is to explain how the Workers Compensation Board determines

More information

Act 16 and Medical Cannabis in Pennsylvania

Act 16 and Medical Cannabis in Pennsylvania Act 16 and Medical Cannabis in Pennsylvania Charles V. Pollack, Jr., MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP Associate Provost and Professor of Emergency Medicine Director, Institute of Emerging Health

More information

Trichomes: Crystalline structures that coat parts of the cannabis plant that hold the majority of the cannabinoid content.

Trichomes: Crystalline structures that coat parts of the cannabis plant that hold the majority of the cannabinoid content. ESSENTIAL MARIJUANA TERMS To more fully understand marijuana, you have to know the language of marijuana. Marijuana has its own language. That s due in part to the complexity of marijuana as a plant, and

More information

CANNABINOIDS: NOVEL MOLECULES WITH SIGNIFICANT CLINICAL UTILITY

CANNABINOIDS: NOVEL MOLECULES WITH SIGNIFICANT CLINICAL UTILITY CANNABINOIDS: NOVEL MOLECULES WITH SIGNIFICANT CLINICAL UTILITY NOEL ROBERT WILLIAMS MD FACOG DIRECTOR OPTIMAL HEALTH ASSOCIATES OKLAHOMA CITY, OKLAHOMA How Did We Get Here? In November 2012 Tikun Olam,

More information

Medical Cannabis use in the Older Patient. Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University

Medical Cannabis use in the Older Patient. Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University Medical Cannabis use in the Older Patient Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University Disclosure Relationships with commercial interests: Grants/Research Support: none Speakers

More information

Medicinal Marijuana: The Canadian Journey

Medicinal Marijuana: The Canadian Journey Medicinal Marijuana: The Canadian Journey Nady el-guebaly MD Professor & Head, Addiction Division, UofC Research Director, Alberta Gambling Research Institute Chief Examiner, ISAM Certification Disclosures:

More information

Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE

Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina) S. Korownyk EDMONTON AB MEDICAL CANNABANOIDS IN PRIMARY CARE Society of Rural Physicians of Canada 26TH ANNUAL RURAL AND REMOTE MEDICINE COURSE ST. JOHN'S NEWFOUNDLAND AND LABRADOR APRIL 12-14, 2018 262 Dr. G. Michael (Michael) Allan EDMONTON AB Dr. Christina (Tina)

More information

Marijuana Education in a Post-Legalization Society Presented on October 31, 2017

Marijuana Education in a Post-Legalization Society Presented on October 31, 2017 Marijuana Education in a Post-Legalization Society Presented on October 31, 2017 by the Co-founder of the Marijuana Education Initiative Molly Lotz, LCSW Today we will be addressing adolescent perceptions

More information

Virtual Lectures Planning Committee Disclosure Summary

Virtual Lectures Planning Committee Disclosure Summary VIRTUAL LECTURES THE ROLL OF MEDICAL CANNABIS: IS IT TIME TO BURN ONE DOWN? MFMER Virtual Lectures Planning Committee Disclosure Summary As a provider accredited by ACCME, College of Medicine, Mayo Clinic

More information

Legislation restricted all narcotics, including cannabis, as poisons required prescriptions antispasmodic

Legislation restricted all narcotics, including cannabis, as poisons required prescriptions antispasmodic Marijuana: Legal History, Neuro-Science & Toxicology LifeSavers Conference Charlotte, North Carolina March 28, 2017 Judge Mary A. Celeste (Ret.) The following presentation may not be copied in whole or

More information

CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE

CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE 1 CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE The Health Effects of Cannabis and Cannabinoids. The Current State of Evidence and Recommendations

More information

Clinical Education Initiative MEDICAL MARIJUANA 101. Speaker: Patricia Reed, PharmD

Clinical Education Initiative MEDICAL MARIJUANA 101. Speaker: Patricia Reed, PharmD Clinical Education Initiative Support@ceitraining.org MEDICAL MARIJUANA 101 Speaker: Patricia Reed, PharmD 8/2/2017 Medical Marijuana 101 [video transcript] 00:00:12 - So we'll get started. Disclosures

More information

Medical Cannabinoids for the Management of Chronic Noncancer Pain

Medical Cannabinoids for the Management of Chronic Noncancer Pain Medical Cannabinoids for the Management of Chronic Noncancer Pain Dr Mark A. Ware MBBS MSc McGill University 12 June 2018 Disclosures Grants: CanniMed Consulting: CHI Inc Emmes 1 Canadian Consortium for

More information

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association The Sale of Cannabis in Pharmacies Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association Development This activity was developed by the American Pharmacists

More information

Medicinal cannabis use among PLWH in the era of legalization

Medicinal cannabis use among PLWH in the era of legalization Medicinal cannabis use among PLWH in the era of legalization June 8, 2017 David Grelotti, MD Assistant Professor University of California, San Diego Center for Medicinal Cannabis Research Outline Overview

More information

Susan Audino, PhD S.A. Audino & Associates, LLC

Susan Audino, PhD S.A. Audino & Associates, LLC Cachexia, Cancer, Chronic Pain, Epilepsy, Glaucoma, HIV, AIDS, Multiple Sclerosis, Nausea, ALS, Crohn s, Hepatitis C, Anorexia, Arthritis, Migraine, Parkinson s, Damage to the Nervous Tissue of the Spinal

More information

Doc, will you sign my medical. Fellow in Hematology/Medical Oncology General Internal Medicine Grand Rounds

Doc, will you sign my medical. Fellow in Hematology/Medical Oncology General Internal Medicine Grand Rounds Doc, will you sign my medical marijuana card? Daniel W. Bowles, MD Fellow in Hematology/Medical Oncology General Internal Medicine i Grand Rounds September 21, 2010 Disclosures Skeptical about marijuana

More information

Medical Cannabis and OMT

Medical Cannabis and OMT Medical Cannabis and OMT David R. Beatty, DO Professor of Osteopathic Principles and Practice, WVSOM November 4, 2017 Objectives At the completion of this presentation the attendee should be able to: 1.

More information

Consumer Information Cannabis (Marihuana, marijuana)

Consumer Information Cannabis (Marihuana, marijuana) Consumer Information Cannabis (Marihuana, marijuana) The courts in Canada have ruled that the federal government must provide reasonable access to a legal source of marijuana for medical purposes. The

More information

Endocannabinoid System Cannabinoid Drugs

Endocannabinoid System Cannabinoid Drugs Cannabinoid Drugs STCM Conference Bern 22.1.2013 Rudolf Brenneisen University of Bern, DKF 1 www.phytopharm.dkf.unibe.ch rudolf.brenneisen@dkf.unibe.ch Milestones 1988: First cannabinoid receptor (rat

More information

Clinical Policy Title: Botanical marijuana for medical use

Clinical Policy Title: Botanical marijuana for medical use Clinical Policy Title: Botanical marijuana for medical use Clinical Policy Number: 00.02.10 Effective Date: January 1, 2015 Initial Review Date: August 20, 2014 Most Recent Review Date: October 19, 2017

More information

OXZGEN FAQ s What is the Endocannabinoid System? What are cannabinoids? What is CBD oil?

OXZGEN FAQ s What is the Endocannabinoid System? What are cannabinoids? What is CBD oil? OXZGEN FAQ s What is the Endocannabinoid System? Discovered only a few decades ago, the endocannabinoid system (ECS) is one of the most important physiological systems in our body. It consists of a group

More information

Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology

Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology 2 Pamela C. Cartright, MAE, RT (R)(T) Assistant Professor and Program Director Radiation Therapy Program

More information

Cannabinoids: access and symptom management in cancer

Cannabinoids: access and symptom management in cancer Cannabinoids: access and symptom management in cancer Appetite stimulation Anecdotal reports suggest marijuana stimulates appetite AIDS/HIV dronabinol 2.5 mg bd v placebo (n=88) increase in appetite 38%

More information

COMPLEMENTARY AND ALTERNATIVE MEDICINE

COMPLEMENTARY AND ALTERNATIVE MEDICINE COMPLEMENTARY AND ALTERNATIVE MEDICINE Allen C. Bowling, MD PhD Colorado Neurological Institute (CNI) Conflict/Disclosure Information Research, consulting, advising, speaking services Acorda, American

More information

Perkins Middle School

Perkins Middle School MARIJUANA AND HEALTH Perkins Middle School February 21, 2017 F u n d e d b y t h e C o u n t y o f S a n D i e g o, H e a l t h a n d H u m a n S e r v i c e s A g e n c y, B e h a v i o r a l H e a l

More information

MEDICAL CANNABIS IN MINNESOTA

MEDICAL CANNABIS IN MINNESOTA MEDICAL CANNABIS IN MINNESOTA EPILEPSY & SEIZURES WELLNESS EXPO APRIL 16, 2016 MICHELLE LARSON, MPA MDH OFFICE OF MEDICAL CANNABIS 2014: Minnesota becomes 22 nd state with a medical cannabis program State

More information

Marijuana and cannabinoids

Marijuana and cannabinoids Psych 181: Dr. Anagnostaras Lec 10: Marijuana Marijuana and cannabinoids Cannabis sativa, hemp One of earliest non-food plants cultivated fiber for rope, seeds for oil and birdseed 1st archaeological evidence

More information

THE IRRATIONAL USE OF MEDICAL MARIJUANA IN CANADA

THE IRRATIONAL USE OF MEDICAL MARIJUANA IN CANADA THE IRRATIONAL USE OF MEDICAL MARIJUANA IN CANADA THE ENDOCANNABINOID SYSTEM Located in brain & throughout peripheral nervous systems Neuromodulatory lipids acting via cannabis receptors Influencing: appetite,

More information

Conflicts of interest

Conflicts of interest David Casarett MD MA Professor of Medicine Chief of Palliative Care Duke University Conflicts of interest SAB: Curio Wellness, Gram Research, Resolve Digital, Clinicann Senior advisor: Silver Swan Capital

More information

THC. A New Perspective

THC. A New Perspective THC A New Perspective TOPICS OF DISCUSSION Legalization THC New Use Cannabis Products THC: A New Perspective 2018 2 LEGALIZATION 3 STATE LEGALIZATION Medicinal 22 States Recreational 8 States plus District

More information

Cannabis: Therapeutic properties of the plant

Cannabis: Therapeutic properties of the plant Cannabis: Therapeutic properties of the plant Medicinal cannabis is still illegal to be used in South Africa. In a victory for marijuana users across South Africa, ConCourt has officially legalised cannabis

More information

Q's &A's of Medical Cannabis in Illinois

Q's &A's of Medical Cannabis in Illinois WHAT IS CANNABIS? Cannabis, also known as marijuana, is a dynamic plant that has medicinal and therapeutic benefits. Chemical compounds in the plant are called cannabinoids and terpenes work together to

More information

Medical Marijuana Update Chris Belletieri, DO

Medical Marijuana Update Chris Belletieri, DO Dr. Belletieri has provided no disclosures. Graduated PCOM in 1996 In private practice since 1999 Board Certified in FP since 1999 Program Director of FP residency at Lower Bucks Hospital in Bristol, PA

More information

Investigational Pharmacy Cannabidiol treatment in Epilepsy

Investigational Pharmacy Cannabidiol treatment in Epilepsy Jon Beck BS Pharm D Coordinator Investigational Pharmacy Disclosure I have no relevant financial relationships with a Commercial Provider Nebraska Medicine Omaha, NE Investigational Pharmacy Cannabidiol

More information

Getting Into the Weed: Potentials and Pitfalls Affecting Medical Use

Getting Into the Weed: Potentials and Pitfalls Affecting Medical Use Getting Into the Weed: Potentials and Pitfalls Affecting Medical Use Cydney E. McQueen, PharmD Clinical Associate Professor UMKC School of Pharmacy Objectives Describe in simple terms the endocannabinoid

More information

Coalition for Medical Marijuana Research & Education

Coalition for Medical Marijuana Research & Education Coalition for Medical Marijuana Research & Education Nagi Kumar, Ph.D., R.D., FADA Professor, Oncologic Sciences Director, Cancer Chemoprevention Executive Director, Coalition for Medical Marijuana Research

More information

Marijuana. DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine

Marijuana. DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine Marijuana DATE: February 21, 2017 PRESENTED BY: Melissa Weimer, DO, Assistant Professor of Medicine Objectives Describe marijuana laws in the state of Oregon and the nation List evidence available for

More information

July 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine

July 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine MEDICAL CANNABIS FOR NEUROLOGICAL DISEASES July 15 TH, 2017 ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine GOALS AND OBJECTIVES

More information

Medical Marijuana for Pain How Does Cannabis Work on Your Body?

Medical Marijuana for Pain How Does Cannabis Work on Your Body? Medical Marijuana for Pain How Does Cannabis Work on Your Body? Jeremy Spiegel, MD Medical Director - Casco Bay Medical Westbury, Long Island, New York Intro Brief History of Cannabis Physiology of Cannabis

More information